Securing the future
On both sides of the Atlantic, political concerns are uppermost in the minds of researchers and product developers, particularly those in the pharmaceutical sector. In the US, the concerns centre on cuts to the governmental funding of science, while in the UK, the focus is on Brexit and all that it entails - from the future of the European Medicines Centre in London to future EU Horizon research funding.
More of the same
British chemical major ICI used to be regarded as a bellwether for the UK economy. If ICI was going well, this meant the UK economy was looking good. Germany’s BASF has been seen by many as a similar bellwether – if not entirely for the European economy, then certainly for the European chemical industry.